Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery

Abstract

The recent emphasis on the development of non-viral transfection agents for gene delivery has led to new physics and chemistry-based techniques, which take advantage of charge interactions and energetic processes. One of these techniques which shows much promise for both in vitro and in vivo transfection involves the use of biocompatible magnetic nanoparticles for gene delivery. In these systems, therapeutic or reporter genes are attached to magnetic nanoparticles, which are then focused to the target site/cells via high-field/high-gradient magnets. The technique promotes rapid transfection and, as more recent work indicates, excellent overall transfection levels as well. The advantages and difficulties associated with magnetic nanoparticle-based transfection will be discussed as will the underlying physical principles, recent studies and potential future applications.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Pankhurst QA, Connoly J, Jones SK, Dobson J . Applications of magnetic nanoparticles in biomedicine. J Phys D 2003; 36: R167–R181.

    Article  CAS  Google Scholar 

  2. Grief AD, Richardson G . Mathematical modelling of magnetically targeted drug delivery. J Magn Magn Mater 2005; 293: 455–463.

    Article  CAS  Google Scholar 

  3. Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B . Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005; 293: 483–496.

    Article  CAS  Google Scholar 

  4. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St Pierre TG et al. Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 15: 1367–1377.

    Article  CAS  Google Scholar 

  5. Yiu HPH, El Haj AJ, Dobson J . Novel iron oxide-silica nanostructured particles for cell biology. Vienna Magnetics Group Report 2005, 14–15 pp. ISBN 3-902105-00-1.

  6. Yiu HPH, Dobson J, El Haj AJ . Internalization of functionalized magnetic nanoparticles into human cells with the use of DOTAP as a transfecting agent. Vienna Magnetics Group Report 2005, 176–177 pp. ISBN 3-902105-00-1.

  7. Cai D, Mataraza JM, Qin ZH, Huang Z, Huang J, Chiles TC et al. Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nature Methods 2005; 2: 449–454.

    Article  CAS  Google Scholar 

  8. Morishita N, Nakagami H, Morishita R, Takeda S-i, Mishima F, Terazono B et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Comm 2005; 334: 1121–1126.

    Article  CAS  Google Scholar 

  9. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F et al. The magnetofection method: using magnetic force to enhance gene therapy. Biol Chem 2003; 384: 737–747.

    Article  CAS  Google Scholar 

  10. Gersting SW, Schillinger U, Lausier J, Nicklaus P, Rudolph C, Plank C et al. Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med 2004; 6: 913–922.

    Article  CAS  Google Scholar 

  11. Krötz F, Sohn HY, Gloe T, Plank C, Pohl U . Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 2003; 40: 425–434.

    Article  Google Scholar 

  12. Schillinger U, Brill T, Rudolph C, Huth S, Gersting SW, Krötz F et al. Advances in magnetofection – magnetically guided nucleic acid delivery. J Magn Magn Mater 2005; 293: 501–508.

    Article  CAS  Google Scholar 

  13. Krötz F, de Wit C, Sohn H-Y, Zahler S, Gloe T, Pohl U et al. Magnetofection – a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003; 7: 700–710.

    Article  Google Scholar 

  14. Krötz F, Engelbrecht B, Buerkle MA, Bassermann F, Bridell H, Gloe T et al. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J Amer Coll Cardiol 2005; 45: 1700–1706.

    Article  Google Scholar 

  15. Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, Welsch U et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004; 6: 923–936.

    Article  CAS  Google Scholar 

  16. Ferrari S, Griesenbach U, Shirai-Iida T, Shu T, Hironaka T, Hou X et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Therapy 2004; 11: 1654–1656.

    Article  Google Scholar 

Download references

Acknowledgements

I am supported by a Wolfson Foundation – Royal Society Research Merit award for this study. I thank the UK Cystic Fibrosis Gene Therapy Consortium & The Cystic Fibrosis Trust for funding support. Professor Eric Alton, Dr Uta Griesenbach, Dr Stefania Xenariou and Dr Stuart McBain are thanked for their helpful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Dobson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dobson, J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther 13, 283–287 (2006). https://doi.org/10.1038/sj.gt.3302720

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302720

Keywords

This article is cited by

Search

Quick links